Cite
Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment.
MLA
Ho, Kuo-Hao, et al. “Glycolysis-Associated LncRNAs Identify a Subgroup of Cancer Patients with Poor Prognoses and a High-Infiltration Immune Microenvironment.” BMC Medicine, vol. 19, no. 1, Feb. 2021, pp. 1–17. EBSCOhost, https://doi.org/10.1186/s12916-021-01925-6.
APA
Ho, K.-H., Huang, T.-W., Shih, C.-M., Lee, Y.-T., Liu, A.-J., Chen, P.-H., & Chen, K.-C. (2021). Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment. BMC Medicine, 19(1), 1–17. https://doi.org/10.1186/s12916-021-01925-6
Chicago
Ho, Kuo-Hao, Tzu-Wen Huang, Chwen-Ming Shih, Yi-Ting Lee, Ann-Jeng Liu, Peng-Hsu Chen, and Ku-Chung Chen. 2021. “Glycolysis-Associated LncRNAs Identify a Subgroup of Cancer Patients with Poor Prognoses and a High-Infiltration Immune Microenvironment.” BMC Medicine 19 (1): 1–17. doi:10.1186/s12916-021-01925-6.